Bloodstream infections due to Trichosporon spp.: Species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing

Journal of Clinical Microbiology

Volumn 47, Issue 4, 2009, Pages 1074-1081

  Chagas Neto, Thomas C ^a   Chaves, Guilherme M ^a   Melo, Analy S A ^a   Colombo, Arnaldo L ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; RIBOSOME DNA; SPACER DNA; VORICONAZOLE; FUNGAL DNA; RIBOSOMAL SPACER DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; CULTURE MEDIUM; FEMALE; FUNGUS CULTURE; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPECIES IDENTIFICATION; TRICHOSPORON; TRICHOSPORON ASAHII; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; FUNGEMIA; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MOLECULAR GENETICS; PHYLOGENY; PRESCHOOL CHILD; PREVALENCE; SOUTH AMERICA;

TRICHOSPORON ASAHII; TRICHOSPORON ASTEROIDES; TRICHOSPORON BEIGELII; TRICHOSPORON COREMIIFORME; TRICHOSPORON DERMATIS;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FEMALE; FUNGEMIA; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MYCOSES; PHYLOGENY; PREVALENCE; SEQUENCE ANALYSIS, DNA; SOUTH AMERICA; TRICHOSPORON;

EID: 65249102150     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01614-08     Document Type: Article

References (54)

1. Ahmad, S., M. Al-Mahmeed, and Z. U. Khan. 2005. Characterization of Trichosporon species isolated from clinical specimens in Kuwait. J. Med. Microbiol. 54:639-646.
2. Asada, N., H. Uryu, M. Koseki, M. Takeuchi, M. Komatsu, and K. Matsue. 2006. Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin. Infect. Dis. 43:e39-e41.
3. Barnett, J. A., R. W. Payne, and D. Yarrow. 2000. Yeasts: characteristics and identification, 3rd ed. Cambridge University Press, Cambridge, United Kingdom.
4. Bayramoglu, G., M. Sonmez, I. Tosun, K. Aydin, and F. Aydin. 2008. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin. Infection 36:68-70.
5. Biasoli, M. S., D. Carlson, G. J. Chiganer, R. Parodi, A. Greca, M. E. Tosello, A. G. Luque, and A. Montero. 2008. Systemic infection caused by Trichosporon asahii in a patient with liver transplant. Med. Mycol. 46:719723.
6. Brito, L. R., T. Guimaraes, M. Nucci, R. C. Rosas, L. Paula Almeida, D. A. Da Matta, and A. L. Colombo. 2006. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med. Mycol. 44:261-266.
7. Chagas-Neto, T. C., G. M. Chaves, and A. L. Colombo. 2008. Update on the genus Trichosporon. Mycopathologia 166:121-132.
8. Colombo, A. L., A. S. Melo, R. F. Crespo Rosas, R. Salomao, M. Briones, R. J. Hollis, S. A. Messer, and M. A. Pfaller. 2003. Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy. Diagn. Microbiol. Infect. Dis. 46:253-257.
9. Colombo, A. L., M. Nucci, B. J. Park, S. A. Nouer, B. Arthington-Skaggs, D. A. da Matta, D. Warnock, and J. Morgan. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44:2816-2823.
10. da Matta, D. A., L. P. de Almeida, A. M. Machado, A. C. Azevedo, E. J. Kusano, N. F. Travassos, R. Salomao, and A. L. Colombo. 2007. Antifungal susceptibility of 1000 Candida bloodstream isolates to 5 antifungal drugs: results of a multicenter study conducted in Sao Paulo, Brazil, 1995-2003. Diagn. Microbiol. Infect. Dis. 57:399-404.
11. De Hoogs, G. S., J. Guarro, J. Gene, and M. J. Figueras. 2000. Atlas of clinical fungi, 2nd ed. Guanabara, Rio de Janeiro, Brazil.
12. Ebright, J. R., M. R. Fairfax, and J. A. Vazquez. 2001. Trichosporon asahii, a non-Candida yeast that caused fatal septic shock in a patient without cancer or neutropenia. Clin. Infect. Dis. 33:E28-E30.
13. Fleming, R. V., T. J. Walsh, and E. J. Anaissie. 2002. Emerging and less common fungal pathogens. Infect. Dis. Clin. N. Am. 16:915-933.
14. Fournier, S., W. Pavageau, M. Feuillhade, S. Deplus, A. M. Zagdanski, O. Verola, H. Dombret, and J. M. Molina. 2002. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Eur. J. Clin. Microbiol. Infect. Dis. 21:892-896.
15. Girmenia, C., L. Pagano, B. Martino, D. D'Antonio, R. Fanci, G. Specchia, L. Melillo, M. Buelli, G. Pizzarelli, M. Venditti, and P. Martino. 2005. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J. Clin. Microbiol. 43:18181828.
16. Gunn, S. R., X. T. Reveles, J. D. Hamlington, L. C. Sadkowski, T. L. Johnson-Pais, and J. H. Jorgensen. 2006. Use of DNA sequencing analysis to confirm fungemia due to Trichosporon dermatis in a pediatric patient. J. Clin. Microbiol. 44:1175-1177.
17. Hata, K., J. Kimura, H. Miki, T. Toyosawa, T. Nakamura, and K. Katsu. 1996. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob. Agents Chemother. 40:2237-2242.
18. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
19. Herbrecht, R., J. Waller, P. Dufour, H. Koenig, B. Lioure, L. Marcellin, and F. Oberling. 1992. Rare opportunistic fungal diseases in patients with organ or bone marrow transplantation. Agressologie 33:77-80. (In French.)
20. Hoy, J., K. C. Hsu, K. Rolston, R. L. Hopfer, M. Luna, and G. P. Bodey. 1986. Trichosporon beigelii infection: a review. Rev. Infect. Dis. 8:959-967.
21. Krcmery, V., Jr., F. Mateicka, A. Kunova, S. Spanik, J. Gyarfas, Z. Sycova, and J. Trupl. 1999. Hematogenous trichosporonosis in cancer patients: report of 12 cases including 5 during prophylaxis with itraconazol. Support Care Cancer 7:39-43.
22. Kustimur, S., A. Kalkanci, K. Caglar, M. Dizbay, F. Aktas, and T. Sugita. 2002. Nosocomial fungemia due to Trichosporon asteroides: firstly described bloodstream infection. Diagn. Microbiol. Infect. Dis. 43:167-170.
23. Lacaz, C. S., E. Porto, J. E. C. Martins, E. M. Neins-Vaccari, and N. T. Melo (ed.). 2002. Tratado de micologia medica, 9th ed. Sarvier Publishers, São Paulo, Brazil.
24. Reference deleted.
25. Marty, F. M., D. H. Barouch, E. P. Coakley, and L. R. Baden. 2003. Disseminated trichosporonosis caused by Trichosporon loubieri. J. Clin. Microbiol. 41:5317-5320.
26. Matsue, K., H. Uryu, M. Koseki, N. Asada, and M. Takeuchi. 2006. Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin. Clin. Infect. Dis. 42:753-757.
27. Melo, A. S., L. P. de Almeida, A. L. Colombo, and M. R. Briones. 1998. Evolutionary distances and identification of Candida species in clinical isolates by randomly amplified polymorphic DNA (RAPD). Mycopathologia 142:57-66.
28. Meyer, M. H., V. Letscher-Bru, J. Waller, P. Lutz, L. Marcellin, and R. Herbrecht. 2002. Chronic disseminated Trichosporon asahii infection in a leukemic child. Clin. Infect. Dis. 35:e22-e25.
29. Middelhoven, W. J., G. Scorzetti, and J. W. Fell. 2004. Systematics of the anamorphic basidiomycetous yeast genus Trichosporon Behrend with the description of five novel species: Trichosporon vadense, T. smithiae, T. dehoogii, T. scarabaeorum and T. gamsii. Int. J. Syst. Evol. Microbiol. 54:975986.
30. Nakajima, M., T. Sugita, and Y. Mikami. 2007. Granuloma associated with Trichosporon asahii infection in the lung: unusual pathological findings and PCR detection of Trichosporon DNA. Med. Mycol. 45:641-644.
31. NCCLS/CLSI. 2002. Reference method for broth dilution antifungal susceptibility testing of yeasts, 2nd ed. Approved standard M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
32. Padhye, A. A., S. Verghese, P. Ravichandran, G. Balamurugan, L. Hall, P. Padmaja, and M. C. Fernandez. 2003. Trichosporon loubieri infection in a patient with adult polycystic kidney disease. J. Clin. Microbiol. 41:479-482.
33. Paphitou, N. I., L. Ostrosky-Zeichner, V. L. Paetznick, J. R. Rodriguez, E. Chen, and J. H. Rex. 2002. In vitro antifungal susceptibilities of Trichosporon species. Antimicrob. Agents Chemother. 46:1144-1146.
34. Pasqualotto, A. C., T. C. Sukiennik, L. C. Severo, C. S. de Amorim, and A. L. Colombo. 2005. An outbreak ofPichia anomala fungemia in a Brazilian pediatric intensive care unit. Infect. Control Hosp. Epidemiol. 26:553-558.
35. Perparim, K., H. Nagai, A. Hashimoto, Y. Goto, T. Tashiro, and M. Nasu. 1996. In vitro susceptibility of Trichosporon beigelii to antifungal agents. J. Chemother. 8:445-448.
36. Pincus, D. H., S. Orenga, and S. Chatellier. 2007. Yeast identification-past, present, and future methods. Med. Mycol. 45:97-121.
37. Ramani, R., S. Gromadzki, D. H. Pincus, I. F. Salkin, and V. Chaturvedi. 1998. Efficacy of API 20C and ID 32C systems for identification of common and rare clinical yeast isolates. J. Clin. Microbiol. 36:3396-3398.
38. Rodriguez-Tudela, J. L., T. M. Diaz-Guerra, E. Mellado, V. Cano, C. Tapia, A. Perkins, A. Gomez-Lopez, L. Rodero, and M. Cuenca-Estrella. 2005. Susceptibility patterns and molecular identification of Trichosporon species. Antimicrob. Agents Chemother. 49:4026-4034.
39. Rodriguez-Tudela, J. L., A. Gomez-Lopez, A. Alastruey-Izquierdo, E. Mellado, L. Bernal-Martinez, and M. Cuenca-Estrella. 2007. Genotype distribution of clinical isolates of Trichosporon asahii based on sequencing of intergenic spacer 1. Diagn. Microbiol. Infect. Dis. 58:435-440.
40. Sidrim, J. J. C., and M. F. G. Rocha. 2004. Micologia médica à luz de autores comtemporǎneos. Guanabara, Rio de Janeiro, Brazil.
41. Soll, D. R. 2000. The ins and outs of DNA fingerprinting the infectious fungi. Clin. Microbiol. Rev. 13:332-370.
42. Sugita, T., M. Nakajima, R. Ikeda, T. Matsushima, and T. Shinoda. 2002. Sequence analysis of the ribosomal DNA intergenic spacer 1 regions of Trichosporon species. J. Clin. Microbiol. 40:1826-1830.
43. Reference deleted.
44. Sugita, T., A. Nishikawa, and T. Shinoda. 1998. Rapid detection of species of the opportunistic yeast Trichosporon by PCR. J. Clin. Microbiol. 36:14581460.
45. Sugita, T., A. Nishikawa, T. Shinoda, and H. Kume. 1995. Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients. J. Clin. Microbiol. 33:1368-1370.
46. Téllez-Castillo, C. J., M. Gil-Fortuno, I. Centelles-Sales, S. Sabater-Vidal, and F. Pardo Serrano. 2008. Trichosporon asahii fatal infection in a preterm newborn. Rev. Chilena Infectol. 25:213-215. (In Spanish.)
47. Tuon, F. F., G. M. de Almeida, and S. F. Costa. 2007. Central venous catheter-associated fungemia due to Rhodotorula spp. -a systematic review. Med. Mycol. 45:441-447.
48. Uchida, K., Y. Nishiyama, N. Yokota, and H. Yamaguchi. 2000. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens. J. Antibiot. (Tokyo) 53:1175-1181.
49. Uzun, O., S. Arikan, S. Kocagoz, B. Sancak, and S. Unal. 2000. Susceptibility testing of voriconazole, fluconazole, itraconazole and amphotericin B against yeast isolates in a Turkish University Hospital and effect of time of reading. Diagn. Microbiol. Infect. Dis. 38:101-107.
50. Walsh, T. J. 1990. Role of surveillance cultures in prevention and treatment of fungal infections. NCI Monogr. 9:43-45.
51. Walsh, T. J., A. Groll, J. Hiemenz, R. Fleming, E. Roilides, and E. Anaissie. 2004. Infections due to emerging and uncommon medically important fungal pathogens. Clin. Microbiol. Infect. 10 (Suppl. 1) :48-66.
52. Walsh, T. J., J. W. Lee, G. P. Melcher, E. Navarro, J. Bacher, D. Callender, K. D. Reed, T. Wu, G. Lopez-Berestein, and P. A. Pizzo. 1992. Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis. J. Infect. Dis. 166:121-133.
53. Walsh, T. J., K. R. Newman, M. Moody, R. C. Wharton, and J. C. Wade. 1986. Trichosporonosis in patients with neoplastic disease. Medicine (Baltimore) 65:268-279.
54. Wolf, D. G., R. Falk, M. Hacham, B. Theelen, T. Boekhout, G. Scorzetti, M. Shapiro, C. Block, I. F. Salkin, and I. Polacheck. 2001. Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units. J. Clin. Microbiol. 39:4420-4425.